Novel calculator more easily identifies patients who will benefit from neoadjuvant chemoradiation
A calculator to guide treatment choice in esophageal cancer has been developed by a team of researchers. The tool helps identify which patients may benefit from treatment before surgery.
Source: ScienceDaily Headlines - Category: Science Source Type: news
More News: Cancer | Cancer & Oncology | Esophagus Cancer | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy